Weill Cornell Medicine received an initial two‑year $5.2 million ARPA‑H LIGHT program grant to develop LANTERN (Lymphatic Disease Advancements with Nanotechnology, Translational Epigenetics, and Research in Genetics). The multidisciplinary effort—led by Lishomwa Ndhlovu with partners at Memorial Sloan Kettering, Georgia Tech and Stanford—aims to create a diagnostic toolbox combining lymphatic biomarkers, genetic/epigenetic readouts and new detection technologies including nanosensors and AI. The project targets a diagnostic gap in lymphatic imaging and hopes to deliver tools translatable across infectious, oncologic and inflammatory indications.